PRU vs STOK · rev $31.19B vs rev $15.6M
PRU (PRU) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
PRU (PRU) common stock.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
PRU currently screens at market cap $0. STOK currently screens at market cap $1.88B.
Not investment advice. Open the PRU and STOK stock pages for the full models.
Not investment advice.